| Patent Number |
Title Of Patent |
Date Issued |
| 6818232 |
Oat extracts: refining, compositions and methods of use |
November 16, 2004 |
| A simple and efficient method for the production of a stable, clear and high-potency oat extract, containing avenanthramide, is disclosed. The method employs the use of a differential dissociation constants and ultra filtration to stabilize extract, prevent the loss of functional activit |
| 6797272 |
Enhanced immunogenicity using leukotoxin chimeras |
September 28, 2004 |
| New immunological carrier systems, DNA encoding the same, and the use of these systems, are disclosed. The carrier systems include chimeric proteins which comprise a leukotoxin polypeptide fused to a selected antigen. The leukotoxin functions to increase the immunogenicity of the ant |
| 6495140 |
Process for the isolation, recovery and purification of non-polar extractives |
December 17, 2002 |
| A process is described for the isolation, recovery and purification of non-polar extractives using one or more extracting solvents from the group of lower alcohols, ketones, and water. The non-polar extractives may include one or more of the classes alk(en)lyresorcinols, steroid, tri |
| 6284886 |
Cereal beta glucan compositions and methods of Formulation |
September 4, 2001 |
| Simple and efficient methods for formulating cereal beta glucan compositions that retard the natural gel forming properties of hydrocolloids and remain free flowing liquids is disclosed. The method employs a biological buffer system consisting of a zwitterionic salt that will vary pH |
| 6086880 |
Rotavirus peptide compositions and methods of use |
July 11, 2000 |
| A number of subunits of various rotaviral proteins have been shown to be useful in diagnosis, therapy, and prevention of rotaviral infection. Specifically, the subunits represented by positions 40-60 of VP6, 232-255 and 240-248 of VP4, and 247-259 and 275-295 of VP7 are thus useful. |
| 5951988 |
Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods |
September 14, 1999 |
| Adjuvant formulations are provided containing quaternary ammonium salts in conjunction with an oil component which may be a mineral oil, an animal oil, a vegetable oil, a mixture thereof, or an oil-in-water emulsion of one or more of such oils. These formulations are useful in conjunctio |
| 5708155 |
Enhanced immunogenicity using leukotoxin chimeras |
January 13, 1998 |
| New immunological carrier systems, DNA encoding the same, and the use of these systems, are disclosed. The carrier systems include chimeric proteins which comprise a leukotoxin polypeptide fused to a selected antigen. The leukotoxin functions to increase the immunogenicity of the ant |
| 5688772 |
Quinoa saponin compositions and methods of use |
November 18, 1997 |
| Novel Quinoa saponin pharmaceutical compositions are disclosed. The compositions are useful for enhancing mucosal absorption of a drug administered therewith. |
| 5597807 |
Quinoa saponin compositions and methods of use |
January 28, 1997 |
| Novel Quinoa saponin pharmaceutical compositions are disclosed. The compositions are useful as immunological adjuvants, to stimulate nonspecific immunity, as well as to enhance an immunological response to a selected antigen. The Quinoa saponin compositions can also be used to enhanc |
| 5503833 |
VP6 encapsulated drug delivery |
April 2, 1996 |
| Compositions and methods for preparing and delivering encapsulated biologically active agents to specific cell types are disclosed. Substances can be encapsulated in the VP6 inner capsid protein of rotavirus and delivered to selected cells, tissues and organs. Targeting agents can be |
| 5431899 |
Rotavirus VP6 as a diagnostic and targeting agent |
July 11, 1995 |
| Advantage is taken of the ability of rotaviral VP6 protein to home to macrophage and monocytes to provide label to these cells in either an in vitro or in vivo environment. Further, the ability to couple label to the VP6 protein and to couple VP6 to a targeting agent provides a mechanism |
| 5422110 |
Enhanced immunogenicity using leukotoxin chimeras |
June 6, 1995 |
| New immunological carrier systems, DNA encoding the same, and the use of these systems, are disclosed. The carrier systems include chimeric proteins which comprise a leukotoxin polypeptide fused to a selected antigen. The leukotoxin functions to increase the immunogenicity of the ant |
| 5298244 |
Assembled viral particles and their use in a vaccine to rotaviral disease |
March 29, 1994 |
| Assembled viral particles derived from rotavirus proteins are disclosed. The assembled particles include the inner capsid protein, VP6, in combination with either or both of the outer capsid proteins, VP4 and VP7. These assemblies can be used in vaccine compositions for the treatment and |
